20-Week Breakout Analysis — 2026-10-28

Overview

The 20-Week Breakout scan recorded 186 total signals on 2026-10-28, split between 100 bullish (dollar_20_wk + pct_20_wk) and 86 bearish (dollar_d20_wk + pct_d20_wk) triggers. The resulting 53.8% bullish / 46.2% bearish split places today’s tape in the Balanced zone — institutional flows are mixed rather than aggressively accumulating, consistent with the SA Regime reading of Cautious despite a “Very Bullish” sentiment overlay.

Breadth of 46.8% above the SMA-40 confirms a market that is neither broadly trending nor broadly breaking down. Leadership in Utilities (2.3% ATR%), Health Care (2.1%) and Materials (1.7%) versus weakness in Real Estate, Technology and Communication Services is directly visible in today’s signal mix: Medical/Biotech names dominate the bullish leaderboard, while cyclical industrials (Aerospace, Metals, Building, Energy) populate the bearish list.

Quality Score: 3/5. In a Cautious regime, only the highest-conviction setups should score 4+. Several top movers (MEDP, TXN, GRAL, ICLR, LH) show strong ATR multiples and sector alignment with Health Care leadership, but institutional fund data is largely unconfirmed (0 funds reported, “undefined” increase%) across the board, capping overall conviction at a moderate 3.

Top 5 Bullish Picks

MEDP ($692.68) — MEDICAL / Medical - Research

Open full analysis on WaveFinder →

Weekly Momentum: MEDP posted an ATR Multiple of 4.04 with ADR% of 2.9%, pushing to within 1.2% of its 52-week high and 85.7% above its 52-week low. Relative volume of 1.1x on 301,526 shares vs. 271,770 average confirms steady, orderly accumulation rather than a volume spike, typical of institutionally-sponsored research/CRO names.

Level	Price
Risk (Support, -1.5x ATR)	$661.06
Current Price	$692.68
Target (+2x ATR)	$734.84

Institutional Interest: 0 funds reported, bucket funds_500 — coverage tier suggests mid-size institutional universe, but no confirmed accumulation increase this cycle.

TXN ($309.83) — CHIPS / Elec-Semiconductor Mfg

Open full analysis on WaveFinder →

Weekly Momentum: TXN’s ATR Multiple of 4.33 and ADR% 2.6% drove the stock 102.9% above its 52-week low, though it remains 7.2% off its high. Volume of 7,307,600 vs. 6,347,240 average (1.1x) signals broad participation in a mega-cap semiconductor name, a rare bullish Technology signal in an otherwise weak sector.

Level	Price
Risk (Support, -1.5x ATR)	$295.80
Current Price	$309.83
Target (+2x ATR)	$328.53

Institutional Interest: 0 funds reported, bucket funds_1000 — the largest coverage tier in today’s scan, implying wide institutional visibility despite unconfirmed flow data.

GRAL ($157.88) — MEDICAL / Medical-Services

Open full analysis on WaveFinder →

Weekly Momentum: The strongest mover on the list, GRAL carries an ATR Multiple of 6.94 and ADR% of 9.0%, up a massive 280.4% from its 52-week low while sitting just 5.2% below its high. High-beta diagnostics momentum with elevated LOD Risk ATR% of 81.6% signals outsized intraday volatility.

Level	Price
Risk (Support, -1.5x ATR)	$142.23
Current Price	$157.88
Target (+2x ATR)	$178.74

Institutional Interest: 0 funds reported, bucket growth_250 — smaller growth-tier coverage, consistent with higher volatility profile.

ICLR ($214.16) — MEDICAL / Medical - Research

Open full analysis on WaveFinder →

Weekly Momentum: ICLR’s breakout featured the highest relative volume in the group at 4.5x average (3,943,436 vs. 867,620 shares), a decisive accumulation signal. ATR Multiple of 5.82 pushed shares to 221.7% above the 52-week low and within 5.0% of the high, but LOD Risk ATR% of 192.1% warns of sharp intraday swings.

Level	Price
Risk (Support, -1.5x ATR)	$199.97
Current Price	$214.16
Target (+2x ATR)	$233.08

Institutional Interest: 0 funds reported, bucket funds_500 — the volume surge is the key conviction signal here, not confirmed fund data.

LH ($360.45) — MEDICAL / Medical-Services

Weekly Momentum: LH broke out with an ATR Multiple of 4.53 on 2.5x relative volume (1,797,316 vs. 717,390 average), trading just 5.5% below its 52-week high and 47.4% above its low. The combination of tight ADR% (2.4%) and strong volume confirms institutional-grade sponsorship in diagnostics.

Level	Price
Risk (Support, -1.5x ATR)	$346.15
Current Price	$360.45
Target (+2x ATR)	$379.51

Institutional Interest: 0 funds reported, bucket funds_1000 — large-cap coverage tier, mirroring TXN’s institutional breadth.

Bearish Alerts

Five bearish 20-week signals highlight distribution in cyclical, capex-sensitive sectors. NVEC (-39.0% off 52-week high, ATR Multiple -2.60) and STRL (-61.3% off high, ATR Multiple -2.53, 2.0x relative volume) show the steepest technical deterioration. WWD (-32.6% off high, ATR Multiple -2.30) and RBC (-27.4% off high) extend weakness into Aerospace/Defense and Metals. VLO rounds out the list with a milder -0.39 ATR Multiple but still -15.8% off its high, reflecting softness in refining margins.

Sector weakness spans Electronics, Energy, Aerospace/Defense, Metals, and Building — a broad cyclical/industrial pullback that aligns with the bottom-sector readings in Real Estate and Technology from the regime data.

Sector Theme

Today’s cross-sector picture shows a clear bifurcation: Health Care and Medical-Services names (MEDP, GRAL, ICLR, LH, TWST, BIO) dominate bullish breakouts, directly confirming Health Care’s position among the Top Sectors by ATR%. Chips (TXN) and Chemicals (HWKN) provide secondary bullish breadth, while Energy is split — AIOK bullish, VLO bearish — reflecting mixed commodity dynamics. The bearish cohort is concentrated in cyclical industrials (Aerospace/Defense, Metals, Building, Electronics), consistent with Cautious-regime rotation out of rate-sensitive and capex-heavy sectors.

Institutional Summary

No tickers in today’s scan reported confirmed institutional fund counts above zero, and funds % increase data was undefined across the board — a notable data gap limiting high-conviction scoring. Bucket tier remains the best available proxy for institutional breadth: TXN and LH sit in the largest funds_1000 tier, MEDP and ICLR in funds_500, and GRAL in the smaller growth_250 tier. Until fund-level accumulation data confirms, traders should treat these breakouts as technically-driven rather than institutionally-validated.

Signals